Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04772235 |
| Title | Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients (TOTEM) |
| Acronym | TOTEM |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Instituto Oncologico Dr Rosell |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hospital Regional Universitario de Málaga | RECRUITING | Málaga | Andalusia | 29010 | Spain | Details |
| Hospital Son Espases | RECRUITING | Palma | Balearic Islands | 07120 | Spain | Details |
| Quiron Dexeus | RECRUITING | Barcelona | Catalonia | 08018 | Spain | Details |
| Hospital Universitario Gregorio Marañón | RECRUITING | Madrid | 28007 | Spain | Details |